Skip to content

Study evaluating uncontrolled systolic blood pressure in middle-aged and older patients with high blood pressure

SYSTUP: Study evaluating uncontrolled SYSTolic blood pressUre in middle-aged and older Patients with hypertension, in relation to stroke risk and current antihypertensive treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN95532888
Enrollment
4242
Registered
2016-09-08
Start date
2016-03-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension (particularly a raised systolic blood pressure) and stroke risk Circulatory System Hypertension (particularly a raised systolic blood pressure) and stroke risk

Interventions

If a potential participant fulfills the inclusion criteria, the investigator will present the main objectives of this study to them and will provide them with an information sheet. If the patient agre
allow the patient to sit for 3-5 minutes before taking measurements, take blood pressure from each arm and use the arm with the higher value as the reference, document the highest of at least two BP m
4. Stroke risk score using Stroke Riskometer™ , where possible (this can be downloaded from Google Play [Android] or App Store [Apple], further details on www.strokeriskometer.com) 5.

Sponsors

Servier International
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age =50 years* (*=60 years in Columbia) 2. Confirmed (in medical records) diagnosis of hypertension 3. Elevated systolic blood pressure (= 140 mm Hg)

Exclusion criteria

Exclusion criteria: Conditions that prevent participation in the study, such as the inability to complete the participant consent form.

Design outcomes

Primary

MeasureTime frame
1. Systolic blood pressure is measured using an auscultatory or oscillometric semiautomatic sphygmomanometer at the study visit 2. Stroke risk is determined using Stroke Riskometer™ at the study visit 3. Antihypertensive use is determined through qualitative interviews at the study visit

Secondary

MeasureTime frame
No secondary outcomes

Countries

Colombia, India, Malaysia

Contacts

Public ContactNathalie Barbet

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026